labetuzumab govitecan

Ligand id: 8252

Name: labetuzumab govitecan

Compound class Antibody
International Nonproprietary Names
INN number INN
10096 labetuzumab govitecan
hMN-14-SN-38 | hMN-14-SN-38 ADC | IMMU 130 | IMMU-130
Labetuzumab govitecan (research code IMMU-130) is an antibody-drug conjugate (ADC) in which the anti-CEACAM5 antibody labetuzumab, is covalently bound to SN-38, the active metabolite of the topoisomerase inhibitor irinotecan (as exemplified in patents [2] and [1]).
Database Links
GtoPdb PubChem SID 249565932
Search PubMed clinical trials labetuzumab govitecan
Search PubMed titles labetuzumab govitecan
Search PubMed titles/abstracts labetuzumab govitecan